Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Just caught the latest round of stock upgrades and downgrades this week and it's worth a quick scan if you're holding any of the big names. Looks like Berkshire Hathaway, CF Industries, and Hologic all got bumped up to Strong Buy status, which usually signals some solid institutional backing. On the flip side, some previously hot stocks like Bank of America and Discover Financial got downgraded from Strong Buy to regular Buy - not necessarily bad news, just a shift in momentum.
I noticed a bunch of interesting moves in the middle tier too. AstraZeneca and Brookfield both jumped from Hold to Buy, which caught my eye given the current market conditions. Meanwhile, names like Carnival and Crown Castle slipped from Buy down to Hold, which feels pretty typical for this market cycle.
The real action is at the bottom end where some stocks took harder hits. CrowdStrike, Marathon Petroleum, and Snap all got downgraded to Sell territory, with a couple like Woodside Energy moving all the way down to Strong Sell. These stock upgrades and downgrades usually reflect shifts in both quantitative metrics and fundamental health, so it's worth checking if any of these align with your current holdings.
If you're actively trading, the key takeaway is that stock upgrades and downgrades like these tend to cluster around quarterly earnings and institutional rebalancing. The downgraded names might be worth watching for potential reversals, but the upgraded ones are probably worth adding to your watchlist. Just my take after scrolling through the data - always do your own homework before making moves.